Scarica l'app Stockscreener
9.64
7.83%
0.70
Dopo l'orario di chiusura:
9.62
-0.02
-0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Ocular Therapeutix vs. Prime Medicine: A 2026 Analysis of Medical Innovation StocksNews and Statistics - IndexBox
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Ocular Therapeutix appoints Jason Robins as CFO and expands stock plan - Investing.com Nigeria
Ocular Therapeutix appoints Jason Robins as CFO and expands stock plan By Investing.com - Investing.com South Africa
Director at Ocular Therapeutix (OCUL) receives RSUs and stock options - Stock Titan
Ocular Therapeutix (OCUL) director granted RSUs and options in new equity awards - Stock Titan
Ocular Therapeutix (OCUL) CFO awarded RSUs and stock options in new equity grant - Stock Titan
Ocular Therapeutix (OCUL) director receives 14,000 RSUs and 44,000 stock options - Stock Titan
Ocular Therapeutix (NASDAQ: OCUL) director receives RSU and option grants - Stock Titan
Ocular Therapeutix (OCUL) director granted RSUs and 44,000 stock options - Stock Titan
Ocular Therapeutix (OCUL) director receives new RSU and stock option awards - Stock Titan
Ocular Therapeutix (NASDAQ: OCUL) expands stock plan and names new CFO - Stock Titan
Ocular Therapeutix, Inc. Appoints Jason Robins as Chief Financial Officer - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Ocular Therapeutix Inc Annual Shareholders Meeting Transcript - GuruFocus
OCUL Q1 2026 Earnings: EPS Misses Estimates as Pipeline Progress Drives Stock HigherGuidance vs Actual - newsline.com
Ocular Therapeutix (OCUL) Edges Lower, Testing Key Support ZoneStandard Deviation - newsline.com
(OCUL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Ocular Therapeutix CMO Nadia Waheed sells $122k in shares - Investing.com UK
Ocular Therapeutix CMO Nadia Waheed sells $122k in shares By Investing.com - Investing.com South Africa
Ocular Therapeutix (OCUL) CMO auto-sells 14,828 shares for taxes - Stock Titan
Assessing Ocular Therapeutix (OCUL) Valuation After Recent Share Price Volatility - Yahoo Finance
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Ocular Therapeutix, Inc. to Participate in Clinical Trials at the Summit 2026 in Las Vegas - Quiver Quantitative
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026 - The Manila Times
Ocular Therapeutix to detail OTX-TKI trial outcomes at Vegas retina summit - Stock Titan
OCUL (NASDAQ: OCUL) Form 144 — 14,828 restricted shares vesting - Stock Titan
OCUL Technical Analysis | Trend, Signals & Chart Patterns | OCULAR THERAPEUTIX INC (NASDAQ:OCUL) - ChartMill
Ocular Therapeutix™ to Host Investor Day on June 17, 2026 - GlobeNewswire
Ocular Therapeutix (OCUL) Valuation Check After Recent Trading And AXPAXLI Growth Expectations - Sahm
Ocular Therapeutix Stock Hits Day High with Strong 7.14% Intraday Surge - Markets Mojo
OCUL Stock Price, Quote & Chart | OCULAR THERAPEUTIX INC (NASDAQ:OCUL) - ChartMill
Ocular Therapeutix CDO Peter Kaiser sells $24,329 in stock By Investing.com - Investing.com India
Ocular Therapeutix chief scientific officer sells $24,747 in stock By Investing.com - Investing.com Nigeria
Ocular Therapeutix chief scientific officer sells $24,747 in stock - Investing.com
Ocular Therapeutix CDO Peter Kaiser sells $24,329 in stock - Investing.com
Liquidity Mapping Around (OCUL) Price Events - Stock Traders Daily
Automatic tax-driven sale and trust transfer by Ocular (OCUL) insider - Stock Titan
Ocular Therapeutix (NASDAQ: OCUL) CDO executes 2,967-share tax sell-to-cover trade - Stock Titan
Ocular Therapeutix (OCUL) CSO sells 3,018 shares to cover RSU taxes - Stock Titan
Ocular Therapeutix (NASDAQ: OCUL) CSO auto-sells 1,858 shares for tax obligations - Stock Titan
Ocular Therapeutix, Inc. (OCUL) Latest Stock News & Headlines - Yahoo Finance
OCUL Q1 2026 Earnings: Wider-than-Expected Loss but Stock Gains on Pipeline ProgressLow Estimate Range - newsline.com
Ocular Therapeutix (OCUL) Rises 3% as Investor Sentiment StrengthensBear Flag - newsline.com
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1 - The Motley Fool
Morgan Stanley (NASDAQ: OCUL) files Rule 144 notice to sell 1,858 shares - Stock Titan
Company (NASDAQ: OCUL) files Form 144 to sell 2,967 shares - Stock Titan
OCUL (NASDAQ: OCUL) files Form 144 proposing sale of 3,018 shares - Stock Titan
Rule 144 notice for 21,156 shares — OCUL (OCUL) - Stock Titan
Ocular Therapeutix Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Ocular Therapeutix (OCUL) Slips Slightly as Stock Holds Key Support at $7.75Option Breadth - newsline.com
Q3 2025 Ocular Therapeutix Inc Earnings Call Transcript - GuruFocus
Q2 2025 Ocular Therapeutix Inc Earnings Call Transcript - GuruFocus
2.60%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):